LHCCX Mutual Fund

LHCCX Mutual Fund

NAV$23.64
See how much of LHCCX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free
Showing top 50 of 63 holdings · as of Apr 30, 2026
LHCCX holdings, by weight
#TickerNameWeightCumulativeSharesMkt valueSectorIndustry
1
LLY
Eli Lilly & Co.Health Care · Pharmaceuticals
8.89%		8.9%775$724.3KHealth CarePharmaceuticals
2—AstraZeneca PLC
4.73%		13.6%2,029$384.9K--
Share changes, sector and industry · Pro
3
GILD
Gilead Sciences
4.25%		17.9%2,647$346.3K
4
JNJ
Johnson & Johnson -
3.19%		21.1%1,129$259.5K
5
NKTR
Nektar Therapeutics
3.17%		24.2%3,038$258.4K
6
NTRA
Natera Inc
2.91%		27.1%1,151$237.3K
7
TARS
Tarsus Pharmaceuticals Inc
2.83%		30.0%3,622$230.4K
8
GH
Guardant Health Inc
2.63%		32.6%2,459$214.1K
9—Argenx Se
2.49%		35.1%259$203.1K
10
NVS
Novartis Ag Ordinary Shares
2.46%		37.6%1,356$200.4K
11
CVS
Cvs Health Corp.
2.37%		39.9%2,320$193.2K
12
MDGL
Madrigal Pharmaceuticals Inc
2.22%		42.1%350$181.1K
13—Intuitive Surg
2.21%		44.4%393$179.8K
14
COGT
Cogent Biosciences Inc
2.19%		46.5%4,983$178.3K
15
GALD
Galderma Group Ag Registered Shares
2.11%		48.7%818$171.6K
16
UNH
Unitedhealth Group Inc
2.10%		50.8%461$170.8K
17
CELC
Celcuity Inc
2.01%		52.8%1,349$163.7K
18
COR
Cencora Inc
1.99%		54.8%525$161.7K
19
BBIO
Bridgebio Pharma Inc
1.99%		56.7%2,278$162.0K
20
ASND
Ascendis Pharma A/S
1.97%		58.7%698$160.1K
21—Abivax Sa Sponsored Adr (1 Ads : 1 Ordinary)
1.87%		60.6%1,296$152.1K
22
EW
Edwards Lifesciences Corp
1.82%		62.4%1,775$148.2K
23—Sold MYR Bought USD 20260409
1.78%		64.2%-$144.8K
24
MIRM
Mirum Pharmaceuticals Inc
1.75%		65.9%1,467$142.8K
25—Ucb Sa
1.74%		67.7%522$142.1K
26
FRGXX
FIMM MM Government Portfolio - Instl Cl
1.72%		69.4%139,927$139.9K
27
DNTH
Dianthus Therapeutics Inc
1.70%		71.1%1,575$138.3K
28
UTHR
United Therapeutics Corp
1.64%		72.7%234$133.7K
29—Nvaesrtex Pharmaceuticals Inc
1.63%		74.4%311$132.9K
30
TMO
Thermo Fisherscientific Inc.
1.48%		75.8%252$120.7K
31
RVMD
Revolution Medicines Inc
1.35%		77.2%764$110.1K
32—Teva Pharmaceutical Industries Limited (Adr)
1.27%		78.5%2,957$103.7K
33
ADPT
Adaptive Biotechnologies Corp
1.17%		79.6%6,769$95.4K
34
PTCT
Ptc Therapeutics Inc
1.12%		80.8%1,401$91.1K
35
INSM
Insmed Inc
1.05%		81.8%630$85.9K
36
MLYS
Mineralys Therapeutics Inc
1.05%		82.8%3,220$85.8K
37—Otsuka Holdings
1.04%		83.9%1,162$84.7K
38
CGON
Cg Oncology Inc
1.00%		84.9%1,223$81.6K
39
RYTM
Rhythm Pharmaceuticals Inc
0.94%		85.8%942$76.6K
40—Beone Medicines Ltd
0.94%		86.8%3,387$76.9K
41
GKOS
Glaukos Corp.
0.93%		87.7%526$75.6K
42
ARWR
Arrowhead Pharmaceuticals Inc
0.87%		88.6%962$70.7K
43
TXG
10x Genomics Inc Com Usd 1 Cl A
0.87%		89.4%3,200$70.6K
44
HTFL
Heartflow Inc
0.86%		90.3%2,360$70.2K
45—Emcompass Health Corp
0.83%		91.1%677$67.7K
46
WGS
Genedx Holdings Corp
0.81%		91.9%1,046$65.8K
47
TMDX
Transmedics Group, Inc.
0.80%		92.7%650$65.5K
48—DBV Technologies S.A. American Depositary Shares, Each Representing One-Half Of Five Ordinary Share, Nominal Value 0.10 Per Share
0.77%		93.5%2,973$62.4K
49—Stryker Corp 3.375 11/25
0.72%		94.2%186$58.6K
50
PTGX
Protagonist Therapeutics Inc
0.70%		94.9%580$57.4K
More holdings · Pro
FundXLS Pro
See the other 13 holdings of LHCCX
X-ray every fund you own at once, ETFs and mutual funds that hold stocks directly, and see how much of your money lands on the same stocks twice.
Unlock FundXLS Pro$45/quarter Pro · Cancel anytime

LHCCX Mutual Fund All Holdings

LHCCX holdings total 64 positions. The top 10 holdings account for 37.6% of the fund, led by Eli Lilly & Co. at 8.9%, AstraZeneca PLC at 4.7%, Gilead Sciences at 4.3%.

LHCCX portfolio concentration is moderate, with the top 10 representing 37.6% of total assets. The largest sector exposure is Health Care at 80.2%.

LHCCX sectors provide a detailed breakdown. LHCCX overlap shows how holdings compare to other funds in your portfolio.